[1]Patent:WO2009/87381,2009,A1.Locationinpatent:Page/Pagecolumn37-38
[2]JournalofMedicinalChemistry,2009,vol.52,p.7170-7185
[1]JournalofMedicinalChemistry,2009,vol.52,p.7170-7185
[1]Patent:CN106467513,2017,A
[1]Patent:CN106467513,2017,A.Locationinpatent:Paragraph0009;0058;0059;0060;0061;0062
Title: The Role of PARP Inhibitors in the Treatment of Gynecologic Malignancies.
Journal: Frontiers in oncology 20130101
Title: Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors.
Journal: Cancer research 20121101
Title: PARP inhibitors: its role in treatment of cancer.
Journal: Chinese journal of cancer 20110701
Title: Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP.
Journal: Journal of hematology & oncology 20110101
Title: Discovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumors.
Journal: Journal of medicinal chemistry 20091126
Title: Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.
Journal: The New England journal of medicine 20090709
Title: Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.
Journal: Nature 20050414
Title: Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.
Journal: Nature 20050414
Title: Jones P, et al. Discovery of 2-{4-[(3S)-piperidin-3-ylphenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumors. J Med Chem. 2009 Nov 26;52(22):7170-85.
Title: Bridges KA, et al. Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells. Oncotarget. 2014 Jul 15;5(13):5076-86.
Title: Wang L, et al. MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation. Invest New Drugs. 2012 Dec;30(6):2113-20.
Title: Mirza MR, et al. Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer. N Engl J Med. 2016 Dec 1;375(22):2154-2164.
